Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 809

1.

Widespread parainflammation in human cancer.

Aran D, Lasry A, Zinger A, Biton M, Pikarsky E, Hellman A, Butte AJ, Ben-Neriah Y.

Genome Biol. 2016 Jul 8;17(1):145. doi: 10.1186/s13059-016-0995-z.

2.

The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins.

Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, Ma'ayan A.

Database (Oxford). 2016 Jul 3;2016. pii: baw100. doi: 10.1093/database/baw100. Print 2016.

3.

Mpath maps multi-branching single-cell trajectories revealing progenitor cell progression during development.

Chen J, Schlitzer A, Chakarov S, Ginhoux F, Poidinger M.

Nat Commun. 2016 Jun 30;7:11988. doi: 10.1038/ncomms11988.

4.
5.

A Mechanistic Beta-Binomial Probability Model for mRNA Sequencing Data.

Smith GR, Birtwistle MR.

PLoS One. 2016 Jun 21;11(6):e0157828. doi: 10.1371/journal.pone.0157828. eCollection 2016.

6.

Targeting MTHFD2 in acute myeloid leukemia.

Pikman Y, Puissant A, Alexe G, Furman A, Chen LM, Frumm SM, Ross L, Fenouille N, Bassil CF, Lewis CA, Ramos A, Gould J, Stone RM, DeAngelo DJ, Galinsky I, Clish CB, Kung AL, Hemann MT, Vander Heiden MG, Banerji V, Stegmaier K.

J Exp Med. 2016 Jun 27;213(7):1285-306. doi: 10.1084/jem.20151574. Epub 2016 Jun 20.

PMID:
27325891
7.

Discovery and validation of the antimetastatic activity of citalopram in colorectal cancer.

Iskar M, Bork P, van Noort V.

Mol Cell Oncol. 2015 Feb 11;2(2):e975080. doi: 10.4161/23723556.2014.975080. eCollection 2015 Apr-Jun.

8.

Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes.

Pan J, Liu S, Farkas M, Consugar M, Zack DJ, Kozak I, Arevalo JF, Pierce E, Qian J, Al Kahtani E.

Mol Vis. 2016 Jun 11;22:636-45. eCollection 2016.

9.

Computational approaches in target identification and drug discovery.

Katsila T, Spyroulias GA, Patrinos GP, Matsoukas MT.

Comput Struct Biotechnol J. 2016 May 7;14:177-84. doi: 10.1016/j.csbj.2016.04.004. eCollection 2016. Review.

10.

Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis.

Malcomson B, Wilson H, Veglia E, Thillaiyampalam G, Barsden R, Donegan S, El Banna A, Elborn JS, Ennis M, Kelly C, Zhang SD, Schock BC.

Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3725-34. doi: 10.1073/pnas.1520289113. Epub 2016 Jun 10.

PMID:
27286825
11.

A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.

Gayvert KM, Dardenne E, Cheung C, Boland MR, Lorberbaum T, Wanjala J, Chen Y, Rubin MA, Tatonetti NP, Rickman DS, Elemento O.

Cell Rep. 2016 Jun 14;15(11):2348-56. doi: 10.1016/j.celrep.2016.05.037. Epub 2016 Jun 2.

12.

Drug combination therapy increases successful drug repositioning.

Sun W, Sanderson PE, Zheng W.

Drug Discov Today. 2016 Jul;21(7):1189-95. doi: 10.1016/j.drudis.2016.05.015. Epub 2016 May 27. Review.

PMID:
27240777
13.

Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds.

Bruni G, Rennekamp AJ, Velenich A, McCarroll M, Gendelev L, Fertsch E, Taylor J, Lakhani P, Lensen D, Evron T, Lorello PJ, Huang XP, Kolczewski S, Carey G, Caldarone BJ, Prinssen E, Roth BL, Keiser MJ, Peterson RT, Kokel D.

Nat Chem Biol. 2016 Jul;12(7):559-66. doi: 10.1038/nchembio.2097. Epub 2016 May 30.

PMID:
27239787
14.

Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.

Jia Z, Liu Y, Guan N, Bo X, Luo Z, Barnes MR.

BMC Genomics. 2016 May 27;17(1):414. doi: 10.1186/s12864-016-2737-8.

15.

An Integrated Data Driven Approach to Drug Repositioning Using Gene-Disease Associations.

Mullen J, Cockell SJ, Woollard P, Wipat A.

PLoS One. 2016 May 19;11(5):e0155811. doi: 10.1371/journal.pone.0155811. eCollection 2016.

16.

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.

Polak A, Kiliszek P, Sewastianik T, Szydłowski M, Jabłońska E, Białopiotrowicz E, Górniak P, Markowicz S, Nowak E, Grygorowicz MA, Prochorec-Sobieszek M, Nowis D, Gołąb J, Giebel S, Lech-Marańda E, Warzocha K, Juszczyński P.

PLoS One. 2016 May 19;11(5):e0155893. doi: 10.1371/journal.pone.0155893. eCollection 2016.

17.

Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action.

Ficek J, Zygmunt M, Piechota M, Hoinkis D, Rodriguez Parkitna J, Przewlocki R, Korostynski M.

BMC Genomics. 2016 May 17;17(1):362. doi: 10.1186/s12864-016-2713-3.

18.

Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS Data.

De Wolf H, De Bondt A, Turner H, Göhlmann HW.

Assay Drug Dev Technol. 2016 May;14(4):252-60. doi: 10.1089/adt.2016.715.

PMID:
27187605
19.

Generating Gene Ontology-Disease Inferences to Explore Mechanisms of Human Disease at the Comparative Toxicogenomics Database.

Davis AP, Wiegers TC, King BL, Wiegers J, Grondin CJ, Sciaky D, Johnson RJ, Mattingly CJ.

PLoS One. 2016 May 12;11(5):e0155530. doi: 10.1371/journal.pone.0155530. eCollection 2016.

20.

A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.

Wen Q, Kim CS, Hamilton PW, Zhang SD.

BMC Bioinformatics. 2016 May 11;17(1):211. doi: 10.1186/s12859-016-1066-x.

Items per page

Supplemental Content

Write to the Help Desk